| |
| |
|
| Insider
Information: |
Riggsbee Richard Bryan |
| Relationship: |
Director |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
309,226 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,405,818 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
309,226 |
|
|
| Total
Value |
$7,405,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Financial Officer |
2023-12-01 |
291,812 |
2014-10-17 |
0 |
Premium* |
|
|
Caredx, Inc. |
CDNA |
Director |
2024-06-14 |
17,414 |
2024-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2019-08-01 |
4 |
AS |
$41.50 |
$1,037,575 |
D/D |
(25,000) |
120,566 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-12-01 |
4 |
AS |
$19.09 |
$572,835 |
D/D |
(30,000) |
291,812 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2018-09-30 |
4 |
D |
$46.00 |
$549,332 |
D/D |
(11,942) |
150,293 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2021-08-03 |
4 |
AS |
$35.14 |
$526,476 |
D/D |
(14,983) |
324,942 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2017-09-30 |
4 |
D |
$36.18 |
$457,388 |
D/D |
(12,642) |
113,510 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2021-09-25 |
4 |
D |
$33.31 |
$396,622 |
D/D |
(11,907) |
373,704 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2021-10-09 |
4 |
D |
$30.88 |
$382,850 |
D/D |
(12,398) |
356,765 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2019-09-25 |
4 |
D |
$29.93 |
$356,766 |
D/D |
(11,920) |
156,146 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2019-09-30 |
4 |
D |
$28.63 |
$341,899 |
D/D |
(11,942) |
144,204 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
AS |
$22.55 |
$338,253 |
D/D |
(15,000) |
337,885 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
D |
$29.69 |
$331,786 |
D/D |
(11,175) |
307,151 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2018-09-25 |
4 |
D |
$46.65 |
$310,362 |
D/D |
(6,653) |
162,235 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2022-12-27 |
4 |
AS |
$15.15 |
$302,992 |
D/D |
(20,000) |
374,107 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2022-02-18 |
4 |
D |
$25.69 |
$287,214 |
D/D |
(11,180) |
393,594 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2022-10-09 |
4 |
D |
$19.62 |
$242,994 |
D/D |
(12,385) |
394,107 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
D |
$25.32 |
$226,766 |
D/D |
(8,956) |
421,504 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-02-18 |
4 |
D |
$19.42 |
$217,931 |
D/D |
(11,222) |
352,885 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-03-24 |
4 |
D |
$23.72 |
$211,796 |
D/D |
(8,929) |
368,665 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-01-20 |
4 |
AS |
$20.04 |
$188,386 |
D/D |
(9,400) |
364,107 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2023-10-09 |
4 |
D |
$15.01 |
$185,163 |
D/D |
(12,336) |
351,812 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2021-09-26 |
4 |
D |
$33.31 |
$151,261 |
D/D |
(4,541) |
369,163 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2020-09-25 |
4 |
D |
$12.44 |
$148,285 |
D/D |
(11,920) |
284,571 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2018-10-17 |
4 |
D |
$44.45 |
$147,885 |
D/D |
(3,327) |
146,966 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2017-10-17 |
4 |
D |
$35.84 |
$126,228 |
D/D |
(3,522) |
109,988 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Financial Officer |
• – – |
2016-09-30 |
4 |
D |
$20.58 |
$115,227 |
D/D |
(5,599) |
69,674 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
